306 related articles for article (PubMed ID: 26904556)
1. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.
Xu L; Kim Y; Spolverato G; Gani F; Pawlik TM
Hepatobiliary Surg Nutr; 2016 Feb; 5(1):43-52. PubMed ID: 26904556
[TBL] [Abstract][Full Text] [Related]
2. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.
Rich NE; Carr C; Yopp AC; Marrero JA; Singal AG
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e267-e288. PubMed ID: 33387668
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
5. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma.
Sempokuya T; Wien EA; Pattison RJ; Ma J; Wong LL
World J Hepatol; 2020 Nov; 12(11):1020-1030. PubMed ID: 33312426
[TBL] [Abstract][Full Text] [Related]
7. Does race affect management and survival in hepatocellular carcinoma in the United States?
Hoehn RS; Hanseman DJ; Wima K; Ertel AE; Paquette IM; Abbott DE; Shah SA
Surgery; 2015 Nov; 158(5):1244-51. PubMed ID: 25958069
[TBL] [Abstract][Full Text] [Related]
8. Comparison of survival between adolescent and young adult
Ren J; Tong YM; Cui RX; Wang Z; Li QL; Liu W; Qu K; Zhang JY; Liu C; Wan Y
World J Gastrointest Oncol; 2020 Dec; 12(12):1394-1406. PubMed ID: 33362910
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States.
Baliga S; Yildiz VO; Bazan J; Palmer JD; Jhawar SR; Konieczkowski DJ; Grecula J; Blakaj DM; Mitchell D; Henson C; Hu K; Yamoah K; Gamez ME
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980667
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
11. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.
Yang D; Hanna DL; Usher J; LoCoco J; Chaudhari P; Lenz HJ; Setiawan VW; El-Khoueiry A
Cancer; 2014 Dec; 120(23):3707-16. PubMed ID: 25081299
[TBL] [Abstract][Full Text] [Related]
12. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in the survival time of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma between Chinese patients and patients of other racial groups: A population-based study from 2004 to 2013.
Ren F; Zhang J; Gao Z; Zhu H; Chen X; Liu W; Xue Z; Gao W; Wu R; Lv Y; Hu L
Oncol Lett; 2018 Dec; 16(6):7102-7116. PubMed ID: 30546445
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study.
Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS
J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in incidence, treatment, and survival in adult brain metastases: a 10-year national database analysis.
Jiang SH; Bhaskara M; Deysher D; Sadeh M; Souter J; Mehta AI
Neurosurg Focus; 2023 Nov; 55(5):E6. PubMed ID: 37913546
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in vestibular schwannoma.
Carlson ML; Marston AP; Glasgow AE; Habermann EB; Sweeney AD; Link MJ; Wanna GB
Laryngoscope; 2016 Sep; 126(9):2128-33. PubMed ID: 26917495
[TBL] [Abstract][Full Text] [Related]
17. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States.
Chikovsky L; Kutuk T; Rubens M; Balda AN; Appel H; Chuong MD; Kaiser A; Hall MD; Contreras J; Mehta MP; Kotecha R
Cancer Epidemiol; 2023 Feb; 82():102317. PubMed ID: 36566577
[TBL] [Abstract][Full Text] [Related]
19. Survival differences in nasopharyngeal carcinoma among racial and ethnic minority groups in the United States: A retrospective cohort study.
Challapalli SD; Simpson MC; Adjei Boakye E; Walker RJ; Antisdel JL; Ward GM; Osazuwa-Peters N
Clin Otolaryngol; 2019 Jan; 44(1):14-20. PubMed ID: 30216675
[TBL] [Abstract][Full Text] [Related]
20. Increased morbidity and mortality of hepatocellular carcinoma patients in lower cost of living areas.
Sempokuya T; Patel KP; Azawi M; Ma J; Wong LL
World J Clin Cases; 2021 Aug; 9(23):6734-6746. PubMed ID: 34447820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
